ProQR Therapeutics Statistics

Total Valuation

PRQR has a market cap or net worth of $134.33 million. The enterprise value is $44.59 million.

Market Cap	134.33M
Enterprise Value	44.59M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

PRQR has 81.66 million shares outstanding.

Shares Outstanding	81.66M
Owned by Insiders (%)	18.87%
Owned by Institutions (%)	39.05%
Float	57.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.16
Forward PS	4.80
PB Ratio	3.59
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.55.

Current Ratio	3.11
Quick Ratio	3.10
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-62.19

Financial Efficiency

Return on equity (ROE) is -61.60% and return on invested capital (ROIC) is -56.52%.

Return on Equity (ROE)	-61.60%
Return on Assets (ROA)	-19.50%
Return on Capital (ROIC)	-56.52%
Revenue Per Employee	$93,980
Profits Per Employee	-$187,040
Employee Count	156
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	-80,618
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.92% in the last 52 weeks. The beta is 0.34, so PRQR's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+0.92%
50-Day Moving Average	1.87
200-Day Moving Average	1.84
Relative Strength Index (RSI)	31.52
Average Volume (20 Days)	104,100

Short Selling Information

Short Interest	196,546
Short Previous Month	241,218
Short % of Shares Out	0.34%
Short % of Float	n/a
Short Ratio (days to cover)	2.29

Income Statement

In the last 12 months, PRQR had revenue of $14.66 million and -$29.18 million in losses. Loss per share was -$0.35.

Revenue	14.66M
Gross Profit	14.50M
Operating Income	-32.83M
Pretax Income	-28.94M
Net Income	-29.18M
EBITDA	-25.62M
EBIT	-28.48M
Loss Per Share	-$0.35

Full Income Statement

Balance Sheet

The company has $110.41 million in cash and $20.67 million in debt, giving a net cash position of $89.74 million or $1.10 per share.

Cash & Cash Equivalents	110.41M
Total Debt	20.67M
Net Cash	89.74M
Net Cash Per Share	$1.10
Equity (Book Value)	37.43M
Book Value Per Share	0.46
Working Capital	78.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.78 million and capital expenditures $6.43 million, giving a free cash flow of -$35.35 million.

Operating Cash Flow	-41.78M
Capital Expenditures	6.43M
Free Cash Flow	-35.35M
FCF Per Share	-$0.43

Full Cash Flow Statement

Margins

Gross margin is 98.89%, with operating and profit margins of -223.95% and -199.02%.

Gross Margin	98.89%
Operating Margin	-223.95%
Pretax Margin	-197.36%
Profit Margin	-199.02%
EBITDA Margin	-174.77%
EBIT Margin	-194.24%
FCF Margin	-241.09%

Dividends & Yields

PRQR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.84%
Shareholder Yield	-0.84%
Earnings Yield	-21.72%
FCF Yield	-26.31%

Analyst Forecast

The average price target for PRQR is $3.38, which is 105.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.38
Price Target Difference	105.47%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	38.25%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3